May Silymarin be selectively considered for nonalcoholic fatty liver disease without elevated transaminases? Comment re. "Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis"
- PMID: 35577653
- DOI: 10.1016/j.nut.2022.111648
May Silymarin be selectively considered for nonalcoholic fatty liver disease without elevated transaminases? Comment re. "Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis"
Comment in
-
Authors' response re. "May Silymarin be selectively considered for nonalcoholic fatty liver disease without elevated transaminases?".Nutrition. 2022 Jun;98:111510. doi: 10.1016/j.nut.2021.111510. Epub 2021 Oct 10. Nutrition. 2022. PMID: 34772595 No abstract available.
Comment on
-
Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis.Nutrition. 2021 Mar;83:111092. doi: 10.1016/j.nut.2020.111092. Epub 2020 Nov 25. Nutrition. 2021. PMID: 33418491